148 related articles for article (PubMed ID: 10786654)
1. Uses of granulocyte-macrophage colony-stimulating factor in vaccine development.
Warren TL; Weiner GJ
Curr Opin Hematol; 2000 May; 7(3):168-73. PubMed ID: 10786654
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model.
Mahdavi M; Tajik AH; Ebtekar M; Rahimi R; Adibzadeh MM; Moozarmpour HR; Beikverdi MS; Olfat S; Hassan ZM; Choopani M; Kameli M; Hartoonian C
APMIS; 2017 Jun; 125(6):596-603. PubMed ID: 28493367
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor as an adjuvant in tumor immunotherapy.
Fagerberg J
Med Oncol; 1996 Sep; 13(3):155-60. PubMed ID: 9106174
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines.
Chang DZ; Lomazow W; Joy Somberg C; Stan R; Perales MA
Hematology; 2004 Jun; 9(3):207-15. PubMed ID: 15204102
[TBL] [Abstract][Full Text] [Related]
5. Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice.
Chen H; Gao N; Wu J; Zheng X; Li J; Fan D; An J
Immunol Lett; 2014 Nov; 162(1 Pt A):140-8. PubMed ID: 25128840
[TBL] [Abstract][Full Text] [Related]
6. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
[TBL] [Abstract][Full Text] [Related]
7. Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF).
Jones TC
Stem Cells; 1994; 12 Suppl 1():229-39; discussion 239-40. PubMed ID: 7696962
[TBL] [Abstract][Full Text] [Related]
8. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses.
Mahdavi M; Ebtekar M; Khorram Khorshid HR; Azadmanesh K; Hartoonian C; Hassan ZM
Immunol Lett; 2011 Oct; 140(1-2):14-20. PubMed ID: 21679728
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination.
Sun X; Hodge LM; Jones HP; Tabor L; Simecka JW
Vaccine; 2002 Jan; 20(9-10):1466-74. PubMed ID: 11818167
[TBL] [Abstract][Full Text] [Related]
10. Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant.
Jones T; Stern A; Lin R
Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S47-53. PubMed ID: 7875153
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
[TBL] [Abstract][Full Text] [Related]
12. Cytokine GM-CSF genetic adjuvant facilitates prophylactic DNA vaccine against pseudorabies virus through enhanced immune responses.
Yoon HA; Aleyas AG; George JA; Park SO; Han YW; Lee JH; Cho JG; Eo SK
Microbiol Immunol; 2006; 50(2):83-92. PubMed ID: 16490926
[TBL] [Abstract][Full Text] [Related]
13. Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines.
Yu TW; Chueh HY; Tsai CC; Lin CT; Qiu JT
Hum Vaccin Immunother; 2016 Dec; 12(12):3020-3028. PubMed ID: 27560197
[TBL] [Abstract][Full Text] [Related]
14. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
[TBL] [Abstract][Full Text] [Related]
15. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
[TBL] [Abstract][Full Text] [Related]
16. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.
Kumar S; Villinger F; Oakley M; Aguiar JC; Jones TR; Hedstrom RC; Gowda K; Chute J; Stowers A; Kaslow DC; Thomas EK; Tine J; Klinman D; Hoffman SL; Weiss WW
Immunol Lett; 2002 Apr; 81(1):13-24. PubMed ID: 11841841
[TBL] [Abstract][Full Text] [Related]
17. Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.
Zhai Y; Zhou Y; Li X; Feng G
Mol Med Rep; 2015 Jul; 12(1):199-209. PubMed ID: 25738258
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine.
Hartoonian C; Ebtekar M; Soleimanjahi H; Karami A; Mahdavi M; Rastgoo N; Azadmanesh K
Cytokine; 2009 Apr; 46(1):43-50. PubMed ID: 19278866
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
Fabrizi F; Ganeshan SV; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(5):789-96. PubMed ID: 16918882
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of adjuvant activities of glucosaminyl-muramyl dipeptide and of the gene coding for granulocyte-macrophage colony-stimulating factor in DNA immunization against herpes simplex virus].
Kozlov AIu; Klimova RR; Shingarova LN; Boldyreva EF; Nekrasova OV; Gur'ianova SV; Andronova TM; Novikov VV; Kushch AA
Mol Biol (Mosk); 2005; 39(3):504-12. PubMed ID: 15981580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
